Ecologically Valid Measures for Deeper Insights
As the leaders in digital biomarkers, Koneksa is proud to play a crucial role in the evolution of oncology trials. Through our research experience and involvement with patient advocacy groups, we have gained a nuanced understanding of patients’ needs. That’s why our solutions are designed to capture a high volume of data obtained during patients’ everyday lives, providing crucial information about the impact of treatments while making it easier for patients to participate.
Koneksa’s oncology solutions facilitate the tracking of measures like heart rate variability (HRV), walking speed, temperature, blood pressure, and step count on a 24/7 basis, eliminating the variability introduced by performance differences in clinic versus at home, and over the course of a day.
Our science-driven approach and ecologically valid measures help you understand the true impact of your treatment:
Signs, not symptoms
Digital biomarkers provide objective evidence for how patients are doing
Ongoing data collection allows for insights that would be impossible to glean solely from sporadic clinic visits
Frequent measures let you closely track changes in health status over time
Oncology Research Is Personal to Us
Everyone knows someone who has been affected by cancer, and our company is no different. Koneksa’s Chief Science Officer, Elena Izmailova, was diagnosed with a malignant tumor at her first colonoscopy, despite having no symptoms and no family history. This led to a colectomy and recovery process for Elena. She was blindsided but proceeded to put her scientific skills to work, assembling a digital kit to collect objective measures of her recovery progress.
She’s not the only member of our family who has been touched by cancer, but she is a perfect example of why we are so committed to using every tool at our disposal to aid its eradication and support patient recovery.
The Data You Need, When You Need It
If patients are improving, you need to know ASAP. The same applies if they are not. In one of Koneksa’s recent studies, we found that daily step count was a predictor of oncology hospitalization, while patients’ most recent quality of life assessments were not.
The value of objective measures is clear
Koneksa specializes in creating solutions that facilitate fast, accurate decisions, saving you time and money and delivering maximum benefit to patients who need oncology treatments that work. Our digital biomarker solutions capture the measures that matter for your trial. Combined with our deep experience in this area, this puts us in a strong position to deliver sharp endpoints and high-quality, actionable measures that matter for your oncology trial.